SNDX - Syndax Pharmaceuticals EPS misses by $0.35 misses on revenue November, 15 2021 04:16 PM Syndax Pharmaceuticals Inc. Syndax Pharmaceuticals (NASDAQ:SNDX): Q3 GAAP EPS of -$0.40 misses by $0.35. Revenue of $12.38M (+3157.9% Y/Y) misses by $17.03M. Press Release For further details see: Syndax Pharmaceuticals EPS misses by $0.35, misses on revenue